Axcelis Expects to Close Veeco Merger by End of First Quarter 2027
Key Facts
Axcelis and Veeco Instruments expect to complete their merger by the end of the first quarter of 2027, while warning that the timing is uncertain and remains subject to meeting closing requirements. Axcelis said in a regulatory filing that approval from China’s State Administration for Market Regulation remains pending and that the companies continue to work with the agency to obtain it. They also plan to submit a new filing under U.S. antitrust law as the current clearance approaches expiration. Closing the deal requires the waiting period associated with the new filing to expire or be terminated early. The revised timing changes the companies’ previous timeline, when they expected to complete the deal in the second half of 2026.
Veeco said in its report for the quarter ended June 30, 2026, that closing was expected in the second half of the year, with final approval from China’s State Administration for Market Regulation still a condition. Axcelis and Veeco reaffirmed the same earlier expectation in their second-quarter reports before moving the timeline to the end of the first quarter of 2027. Shareholders of both companies voted in favor of the agreement on February 6, 2026, but shareholder approval did not complete the remaining regulatory procedures. That leaves the new U.S. antitrust filing, alongside Chinese approval, among the steps on which completion of the deal still depends. The companies did not specify a guaranteed date beyond this conditional expectation in the filing.
The merger agreement dates to September 30, 2025, and provides for Veeco to become a wholly owned subsidiary of Axcelis. The transaction is an all-stock exchange, with Veeco shareholders receiving 0.3575 shares of Axcelis for each Veeco share they own at closing. The final consideration to shareholders is therefore tied to completion of the deal under the agreement’s terms, which still awaits satisfaction of the regulatory conditions. When they announced the deal, the companies valued the combined entity at about $4.4 billion, based on closing share prices on September 30, 2025, and outstanding debt as of June 30, 2025. That figure was an estimate announced at the time of the agreement, not a fixed cash price for each Veeco share.
The companies presented the deal as a combination of complementary technologies and diversified end markets, and said the new entity’s total addressable market exceeds $5 billion. They estimated annual cost synergies of about $35 million within 24 months of completing the merger, with most expected to be realized in the first 12 months. In a pro forma presentation of 2024 performance, they said combined revenue was $1.7 billion, non-GAAP gross margin was 44%, and adjusted EBITDA was $387 million before synergies. These figures provide financial and strategic context for the deal, while the extended timeline delays its implementation. In Veeco’s second-quarter 2026 report, semiconductor revenue rose 5% year over year, accounting for 68% of total quarterly revenue.
Veeco shares closed at $38.87 on October 30, 2026, according to EL7 daily data. That figure gives the stock’s closing price on that day, but by itself does not establish the direction of the market’s response to the revised deal timeline. Regulatory closing conditions remained in place under the agreement, including Chinese approval and the new U.S. waiting period. The available data did not include a comparison price or other daily move that would allow the impact of the change on the stock to be measured. The next expected closing date remains the end of the first quarter of 2027, subject to satisfaction of the conditions and expiration of the waiting period or its early termination.